Beam Therapeutics Inc is trading at $30.71 (-6.47%) as it reverses after a prior session spike amid broader market weakness.
- The stock is giving back a portion of its 11.13% gain from June 4, with no new company-specific catalysts identified for today's decline.
- Macroeconomic pressure is impacting the biotech sector, as the S&P 500 drops 0.95% and the Nasdaq Composite falls 1.51%.